Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Quantification of Bcr-Abl transloaction by Real Time PCR

Quantification of Bcr-Abl transloaction by Real Time PCR

Quantitative BCR-ABL test is used for the accurate quantification of BCR-ABL p210 transcripts in   peripheral blood samples of Acute Lymphoblastic Leukaemia (ALL) or Chronic Myeloid (CML)  patients previously diagnosed with a BCR-ABL Mbcr Fusion Gene (FG) event. The results obtained can be used to monitor efficiency of treatment in patients undergoing therapy and for Minimal Residual Disease (MRD) follow-up to monitor disease relapse.

Last updated on : January 12, 2023 3:19am